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Although cd Tcells are involved in the response to many pathogens, the dynamics and
heterogeneity of the local cd T cell response remains poorly defined. We recently
identified cd T cells as regulators of macrophages and dendritic cells during the
resolution of Streptococcus pneumoniae-mediated lung inflammation. Here, using PCR,
spectratype analysis and flow cytometry, we show that multiple cd T cell subsets,
including those bearing Vc1, Vc4 and Vc6 TCR, increase in number in the lungs of
infected mice, but not in associated lymphoid tissue. These cd Tcells displayed signs of
activation, as defined by CD69 and CD25 expression. In vivo BrdU incorporation
suggested that local expansion, rather than recruitment, was the principal mechanism
underlying this increase in cdTcells. This conclusion was supported by the finding that
pulmonary cd Tcells, but not ab Tcells, isolated from mice that had resolved infection
exhibited lung-homing capacity in both naive and infected recipients. Together, these
data provide novel insights into the origins of the heterogeneous cd Tcell response that
accompanies lung infection, and the first evidence that inflammation-associated cd
T cells may exhibit distinct tissue-homing potential.
Introduction
cdTcells are a rare population of T lymphocytes in most
tissues. The cd TCR
+ population can be subdivided
based onthe expressionofspecificVcandVd TCRchains
[1], defined here using the nomenclature of Heilig and
Tonegawa [2]. The resultant clonal and oligoclonal
subsets may preferentially associate with specific tissues
[3]. For example, expression of the Vc5 chain is
predominantly restricted to dendritic epithelial cd
T cells found in skin [4] and Vc6
+ cells are the major
reproductive tract cd T cell population [5]. In contrast,
heterogeneous populations of cd T cells are found in
other tissues, including the lung.
Lung cd T cells comprise predominantly Vc1
+ and
Vc4
+ subsets, with Vc6
+ cells also present [6–8]. These
subsets may have distinct functions, often acting as
immunoregulatory cells. For example, Vc1
+ cells
promote airway hyper-responsiveness, whereas Vc4
+
cells suppress this activity [9]. In a model of chronic
pulmonary fibrosis, canonical Vc6
+ cells may down-
regulate ab T cell-mediated pathology [10]. Contrast-
ingly, both Vc1
+ and Vc4
+ subsets contribute to
cytokine production during infection with influenza
[11, 12], or following mycobacterial exposure [13].
Immunoregulatory cd T cell responses associate with a
range of pulmonary infections, including Nocardia
asteroides [14], Klebsiella pneumoniae [15] and Crypto-
coccusneoformans[16].However,ingeneral,therelative
contributions of specific subsets to these responses have
not been determined.
Substantial evidence exists therefore to place cd
Tcells as central immunoregulatorycells notonly within
the lung but in many tissues [3, 17]. Despite the
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priate immune responses, cd T cells remain relatively
poorly characterized during responses to infection.
During resolving Streptococcus pneumoniae-induced
lung inflammation [18, 19], cd T cell numbers increase
>30-fold and are responsible for regulating macrophage
and dendritic cell numbers during the resolution phase
of inflammation [20]. Using RT-PCR, spectratyping,
flow cytometry and analysis of cell cycle progression,
thesecdTcellsareshownheretorepresentanexpansion
of multiple lung-resident cd Tcell subsets and to have an
activated phenotype. The response is lung restricted,
and cd T cells isolated from resolving lungs preferen-
tially home back to the lungs of recipient mice in an
inflammation-independent manner. Together, these
data provide new insights into the lung cd T cell
population and their tissue-specific nature.
Results
Multiple Vc chain-expressing cd Tc e l l
populations in naive and inflamed lungs
Data characterizing cd T cells during pathogen-induced
responses remain sparse. We have used a model of
resolving S. pneumoniae infection [18, 19] to examine
the pulmonary cd T cell response following local
pathogen-induced inflammation [20]. In this model,
intranasal challenge with S. pneumoniae serotype 6B
had little effect on the numbers of lung CD4
+ or CD8
+
Tcell populations (Fig.1A) over the subsequent 14 days.
In contrast, the pulmonary cd T cell population was
significantly increased, with a >30-fold increase in cd
T cell number observed at the peak of the response
(days 7–10; Fig. 1A). While the cd T cell response
subsequently subsided, it remained significantly ele-
vated at day 14 compared with naive controls (Fig. 1A).
Given this striking change in the lung cd T cell
population, we next addressed whether one or more
specific cd T cell subsets were responding to
S. pneumoniae challenge. Qualitative PCR analysis of
highly purified lung cd Tcells from naiveanimals (n =4
pools of six mice) showed a mixed population, with
mRNA for Vc1, Vc2, Vc4, Vc5 and Vc6 detectable
(Fig. 1B). Analysis of cd T cells purified at day 7 post
S. pneumoniae challenge (n = 6 pools of three to six
mice) also showed expression of mRNA for Vc1, Vc2,
Vc4, Vc5and Vc6. The Vc5 chain commonly associates
with Vd1inDETC, althoughexpressionof mRNAfor Vd1
was barely detectable in cd T cells purified from naive
lung. In contrast, mRNA for Vd1 was consistently
detectable in samples from day 7 post challenge
(Fig. 1B). Vc7 mRNA was not detected in any samples
from either naive or infected mice.
In contrast with the lung, sorted cd T cells from the
draining LN of naive (n = 3 pools of three to six mice)
and S. pneumoniae-challenged mice (n = 3 pools of
three to six mice) expressed only Vc1, Vc2 and, weakly,
Vc4 mRNA (Fig. 1B).
Expansion of Vc1
+ and Vc4
+ cd T cells following
pneumococcal challenge
To confirm the PCR analysis and to obtain quantitative
data regarding cd Tcell subsets, flowcytometric analysis
of Vc1, Vc4, Vc5 and Vd6.3 expression was carried out
on total lung cells. In naive mice, Vc1
+ cells represented
a mean 12.1  2.0% (n = 9) of total cd Tcells. At day 7
following S. pneumoniae challenge, this proportion was
maintained, with 13.5  1.1% (n = 12) of cd T cells
expressing Vc1 (Fig. 2A). Accounting for the increased
total viable lung cell number associated with inflamma-
tion, a significant increase in the mean number of Vc1
+
cells results following pneumococcal challenge. The
Figure 1. Pulmonary cd T cells increase following S. pneumoniae
challenge. (A) Gated CD3
+TCRb
+CD4
+, CD3
+TCRb
+CD8
+ and
CD3
+TCRb
–TCRd
+ populations in the lung were examined in
naive mice and at various time points following S. pneumoniae
challenge. The fold increase in absolute number of each
population at days 1–14 following challenge is shown. The
graph represents 6–18 mice at each time point. *p <0.05 vs.
naive control by Student's t-test. (B) Purified cd T cells from
naive (N) lung, or from lung at day 7 post S. pneumoniae
challenge, were analyzed for mRNA encoding various Vc
chains or the Vd1 chain, with b-actin (b) expression used as a
control. Draining LN cd T cells were analyzed in comparison.
Representative samples are shown in each case.
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+ cells rose from
3.6  0.6  10
3 in naive mice, to 1.25  0.1  10
5 at
day 7 (p <0.001; Fig. 2B), a 35-fold increase.
Vc4
+ cells were also well represented among cd
T cells in the naive lung (mean 21.5  1.5%) (Fig. 2A).
While pneumococcal challenge resulted in a significant
decrease in the relative proportion of Vc4
+ cells at day 7
(12.3  1.2%; p = 0.001), this represented an almost
20-fold increase in their absolute number, from a mean
of 6.5  0.4  10
3 cells/lung in naive mice to
1.14  0.1  10
5 at day 7 (p <0.001; Fig. 2B).
Expression of the Vd6.3 chain, which can associate
with Vc1 [21], was consistently restricted to a small
proportion of naive lung cd T cells (mean 1.9  0.3%),
which was reduced to 0.3  0.2% at day 7. While this
translated to a fourfold increase in the mean number of
these cells in the lung, they remained relatively
infrequent at day 7 (mean 2.6  1.4  10
3 cells/lung).
No distinct Vc5
+ population was present in either naive
animals or following S. pneumoniae challenge, as
determined by flow cytometry. The increase in number
of both the Vc1 and Vc4 subsets, as well as of the
remaining undefined cd Tcells, followed similar kinetics
(Fig. 2B). That is, in each case, the majority of the
increase occurred between days 5 and 7 post challenge
and peaked at days 7–10.
In comparative stainings of naive draining LN
(Fig. 2C), >75% of cd T cells expressed either Vc1o r
Vc4. These results indicate that a significant proportion
of lung cdTcells(>65%innaiveand>75%ininfection)
remainunidentifiablebythecurrentpanelofantibodies,
which is not due to an inability of the antibodies to
recognize their specific TCR in our hands. PCR analysis
(Fig. 1B) suggests that these cells may comprise Vc2
+
and/or Vc6
+ cells, for which antibodies are not
available. Nevertheless, together these results clearly
demonstrate that S. pneumoniae challenge results in
increased numbers of multiple cd T cell subsets in the
lung.
Non-productive Vc5 transcripts are present in
lung cd T cells
The expression of Vc5 mRNA in naive and inflamed
lungs was unexpected, since Vc5
+ Tcells are reportedly
restricted to skin [4], with minor populations found in
murine mammary gland [22] and in spleens of Vc1
–/–
mice [23]. However, expression of cell surface Vc5
protein was not detected by flow cytometry (Fig. 2A).
We therefore carried out spectratyping analysis of PCR
products to determine whether the Vc5 transcripts were
putatively productive.
The canonical, oligoclonal dendritic epithelial cd
Tcell population has Vc5 spectratype lengths of 142 and
145 bp [23]. However, Vc5 transcripts from both naive
cd T cells and cd T cells from S. pneumoniae-challenged
mice comprised spectratypes ranging from 126 to
142 bp. The in-frame, 142-bp spectratype was among
the least represented of those observed, with no
apparent bias towards other putative productive, in-
frame transcripts (139, 136, 133 and 130 bp) compared
with non-productive (out-of-frame) spectratypes
(Fig. 3A). In contrast, analysis of Vc4 PCR products
showed dominant (>90%) expression of the major
productive (183 and 186 bp) spectratypes (Fig. 3B).
Together, flow cytometry and spectratype data strongly
suggest that Vc5-expressing Tcells do not occur in naive
lung, and are not induced following S. pneumoniae
challenge.
Figure 2. Expression of Vc/Vd chains assessed by flow
cytometry. (A) Total lung cells from naive mice, or mice
challenged 7 days previously with S. pneumoniae were stained
for the expression of various Vc chains and of Vd6.3. Cells
shown are gated on size and granularity, and as
CD3
+TCRb
–TCRd
+ cells. Six to twelve individual mice, or pools
of at least three mice (naive only), were analyzed in each case.
(B) Absolute numbers of Vc subsets in naiveand S. pneumoniae-
challenged lungs at various time points. Bars represent mean
( 1 SD) Vc1 (open bars), Vc4 (closed bars) or Vc1
–Vc4
–TCRd
+
cells in total lung (ND, not defined: hatched bars). (C) Draining
LN cells from naive mice stained as for (A).
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following S. pneumoniae challenge
To determine whether lung cd T cells are activated as a
result of S. pneumoniae challenge, activation-associated
surface marker expression and inflammatory cytokine
production were examined by flow cytometry. In naive
lungs, significantly more cd T cells were CD44
HI (mean
72.6  5.0%) than were ab T cells from the same
individuals (22.6  1.6%, p = 0.001). Similarly,
43.3  4.9% of naive lung cd T cells expressed the
early activation marker CD69, compared with only
2.1  0.3%% of naive ab T cells (p = 0.004; Fig. 4A).
At day 7 following S. pneumoniae challenge,
92  3% of cd T cells were CD44
HI, significantly
increased from naive levels (p <0.01.). While CD44
HI
ab T cells were also increased compared with naive
controls (50.4  1.9%; p <0.01), they remained sig-
nificantly less represented than among cd T cells at the
same time point (p <0.001; Fig. 4A). A similar pattern
was observed for CD69 expression, where the propor-
tions of both cd (83  5%) and ab Tcells (36.0  4.1%)
expressing CD69 at day 7 post challenge were increased
compared to their naive counterparts (p <0.01 in both
cases). However, CD69 expression among cd T cells
remained more prevalent than among the ab T cell
population in the lung (p <0.001; Fig. 4A). At day 7
following challenge, 75  3% of cd T cells were
CD44
+CD69
+, in comparison to only 27.2  2.4% of
ab T cells (p <0.001; Fig. 4B).
The expression of CD25, a marker of Tcell activation
in vitro while associated with a regulatory T cell
phenotype in vivo [24], further delineated the two
Tcell populations. Whereas the vast majority (>95%) of
cd T cells from naive lungs were CD25
–, cd T cells
examined at day 7 following pneumococcal challenge
showed expression of CD25. In comparison, naive lung
ab T cells were CD25
–, and remained so following
S. pneumoniae challenge (Fig. 4C).
Previous studies have associated cd T cell function
with the production of soluble mediators [25], including
cytokines [12, 26–28]. However, ex vivo intracellular
flow cytometry performed without exogenous stimuli
did not detect expression of TNF, IFN-c, IL-12/23 p40,
IL-10 or IL-4 within cd T cells from naive mice, or from
mice at days 1, 3, 7, 10 and 14 post challenge.
Quantitative real-time RT-PCR analysis of mRNA from
purified, non-stimulated cd Tcells further confirmed no
consistent change in cytokine mRNA accumulation
(data not shown).
To determine whether the commitment of lung cd
T cells for cytokine production changed as a conse-
quence of inflammation, lung cells were incubated in
the presence of PMA and ionomycin prior to staining for
cytokine expression. Given this stimulation, a high
proportion of lung cd Tcells from naive mice expressed
IFN-c (35.4  7.6%; Fig. 5), with few cells expressing
detectable levels of IL-10 (1.3  0.4%) or IL-4
(4.3  1.8%). During the peak of the response, at
day 10, the proportion of IFN-c-positive cd T cells was
significantly reduced to 17.7  3.4% (p = 0.04; n =5 ;
Fig. 5). Given the overall 30-fold increase in lung cd
Tcell number, these data indicate quantitative increases
in cd T cells with IFN-c-producing capability at this
stage of the response (mean 1.8  0.3  10
5 IFN-c
+
cells) compared with naive mice (mean
0.1  0.02  10
5). In contrast to cd T cells, the
proportion of IFN-c-positive CD4
+ Tcells was increased
at this time point (12.5  4.2%) compared with naive
mice (7.1  1.8%; p = 0.05) Among cd T cells, the
proportion of IL-10- (0.5  0.2%; p = 0.06) and IL-4-
positive (1.7  0.9%; p =0 . 1 2 ) cd T cells also ap-
peared to be somewhat, though not significantly,
reduced. Together, these data demonstrate lung cd
T cell activation as a result of S. pneumoniae challenge,
with elevated expression of activation markers occur-
ring in the absence of significant increases in the
proportion of cells capable of expressing common
effector cytokines.
Figure 3. Spectratype analysis of putative pulmonary Vc5
mRNA transcripts. PCR products from mRNA analysis of lung
cd T cells (Fig. 1B) were excised, purified and spectratyped. The
mean relative frequencies ( 1 SEM; y axis) of spectratypes
(x axis) from (A) Vc5( n = 12) and (B) Vc4( n = 6) PCR products is
shown. (A) The canonical Vc5 (DETC) spectratype at 142 bp is
indicated (arrow) and other putative in-frame spectratypes are
circled.
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Despite clear increases of cd T cell numbers during
inflammatory responses, the role of local expansion
versus recruitment in this process has been implied [10,
11, 13] but not directly addressed. It was of significant
interest to determine whether S. pneumoniae-induced
cd T cells arise through recruitment to the lung from
other sites or by expansion of resident lung cd T cells.
Our flow cytometric data demonstrated no prominent
increase or decrease in cd T cell numbers in the spleen,
blood and draining LN of S. pneumoniae-challenged
mice, compared with lung (data not shown), supporting
a model in which S. pneumoniae-induced inflammation
results in expansion of a previously resident, lung-
specific cd T cell population. Therefore, lung ab and cd
T cells were examined to determine whether these
populations were undergoing expansion through divi-
sion.
In naive mice, similar percentages of lung cd
(12.8  2.5%)andabTcells(9.1  3.0%)incorporated
BrdU over a 7-day labeling period (Fig. 6). At day 7
following S. pneumoniae challenge, BrdU
+ cd T cells
were significantly increased compared with naive mice
(42.2  8.1%; n =6 ,p <0.01). Furthermore, lung cd
Tcellturnoveratthistimepointwassignificantlygreater
(p <0.05) than that of lung ab T cells (31.2  4.1%;
n = 6) (Fig. 6). Examination of cd T cells from the
spleen and draining LN of mice at day 7 post challenge
did not reveal any significant increase in BrdU
incorporation compared with naive controls (p >0.05;
data not shown).
Figure 4. Lung cd T cells have a highly activated phenotype. Lung cd (CD3
+TCRb
–TCRd
+)o rab (CD3
+TCRb
+TCRd
–) T cells from naive
(N; n = 6) mice, or mice challenged 7 days previously with S. pneumoniae (n = 6) were stained for the expression of the activation
markers CD44 and CD69. (A) Numbers indicate percentages of CD44
HI and CD69
HI cells among cd (left panels) and ab (right panels)
T cells, gated relative to isotype control mAb staining (not shown). (B) Gated cd (left plot) and ab (right plot) T cells from day 7 post
challengeanalyzedforconcomitantexpressionofCD44andCD69.GatedCD44
HICD69
HIcellsareshown,alongwiththepercentage
of CD44
HICD69
HI cells. (C) Gated cd (left plots) and ab (right plots) T cells from naive or day 7 mice analyzed for CD25 expression.
Gates indicate CD25
+ cells. All axes represent log fluorescence intensity and representative plots are shown.
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capabilities
Tissue-specific association of cd Tcells may be reflected
in their trafficking abilities, with Vc5
+ cells most clearly
shown to have skin-homing capability [29, 30]. To
examine whether cd or ab T cells from S. pneumoniae-
challenged mice were able to traffic specifically to the
lung, day 7 cd and ab T cell populations from CD45.1
+
donors were labeled with CFSE and transferred into
naive CD45.2
+ recipients. At 48 h post transfer,
CD45.1
+CFSE
+ donor cd T cells preferentially located
in the lung, where theycomprised a significantly greater
proportion of total CD3
+ cells than in other organs
examined (Fig. 7A). Accounting for differences in CD3
+
cells in each organ, it is estimated that 40% of the
recoveredCD45.1
+CFSE
+ donorcd Tcells werefound in
the lung, with approximately 50% in the spleen. In
contrast, only 10% of the recovered ab T cells were
found in the lung, with more than 85% associated with
the spleen. This preferential lung-specific localization
also occurred following S. pneumoniae challenge. Thus,
transfer at day 3 post S. pneumoniae challenge resulted
in a similar distribution of CD45.1
+CFSE
+ donor cd
T cells at 1 or 4 days post transfer (day 4 or day 7 post
challenge for recipients) (Fig. 7A). In contrast, ab Tcells
purified from lungs of the same donors did not show
preferential lung homing. Donor ab T cells were
detected at equivalent proportions in all organs of both
naive and infected recipients that were examined
(Fig. 7B). Again, accounting for differences in CD3
+
cells in each organ at 4 days post transfer, over 50% of
CD45.1
+CFSE
+ donor cd Tcells were found in the lung,
andonly40%inthespleen.ForabTcells,approximately
15% of the recovered cells were found in the lung, with
65% associated with the spleen. This suggests that
tissue-associated inflammatory signals are not required
for, but may enhance, homing of lung-derived cd Tcells.
Figure 5. Capability of lung cd T cells for cytokine expression.
Lung cells from naive or S. pneumoniae-challenged mice (n =5 )
at day 10 post challenge were stimulated in vitro with PMA and
ionomycin in the presence of brefeldin A prior to flow
cytometric analysis of cytokine expression. Gated cd
(CD3
+TCRb
–TCRd
+) T cells stained for IFN-c (left panels), IL-10
(centre panels) and IL-4 (right panels) are shown (all on y axis).
Numbers indicate percentages of cytokine-positive cells,
within the gates shown, among cd T cells. Axes represent log
fluorescence intensity and representative plots are shown in
each case.
Figure 6. Turnover of pulmonary cd T cells. Naive or
S. pneumoniae-challenged mice given BrdU for 7 days to assess
cd T cell turnover. Plots show BrdU incorporation into gated cd
(upper plots) or ab T cells (lower plots) at each time point. No
positive staining was observed with isotype control mAb (data
not shown).
Figure 7. Preferential lung homing of pulmonary cd T cells.
Purified, CFSE-labeled (A) cd T cells or (B) ab T cells were
adoptively transferred into naive recipients and analyzed 48 h
later, or into recipients at day 3 post S. pneumoniae challenge
and analyzed 24 or 96 h later. Data represent (y axis) mean
( 1 SD) CFSE
+ donor cells/10
3 CD3
+ cells in each organ (n =6
per group in two separate experiments).
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Using an S. pneumoniae-induced model of pulmonary
inflammation, this study has examined in detail the cd
T cell population involved in the ensuing immune
response. A substantially increased pulmonary cd T cell
population arises as a result of pneumococcal challenge
[20], and here we demonstrate the coincident involve-
ment of multiple cd T cell subsets. While a significant
proportion of naive lung cd Tcells exhibited an activated
phenotype, activation was clearly enhanced in infected
mice, most notably in respect to CD25 expression.
Finally, increased BrdU uptake and the preferential
lung-homing capability of lung cd T cells following
pneumococcal challenge strongly suggest that local
division, rather than recruitment, is responsible for this
infection-induced increase in cd T cell number.
Intranasal S. pneumoniae serotype 6B challenge
induced a >30-fold increase in pulmonary cd T cells,
without compensatory or complementary changes with-
in draining LN, blood or spleen. This expanded
population of cd T cells has cytotoxic activity against
alveolar macrophages and lung dendritic cells, and acts
to regulate these populations during resolution of
inflammation [20]. However, in this and other infection
models, immunoregulatory functions have been as-
cribed to bulk cd Tcells without detailed analysis of the
receptor repertoire of the responding populations [12,
15, 16, 20, 28, 31]. Here, we have quantified Vc1
+ and
Vc4
+ cells in naive lungs, confirming and extending
recent immunohistochemical studies [8]. Flow cyto-
metric analyses were unable to account for a significant
proportion of lung cd Tcells in both naive and inflamed
lungs, in contrast to those in draining LN, which may
include pulmonary Vc6
+ cells [8]. While Vc6
+ cd Tcells
have recently been identified by application of the anti-
Vc5 mAb 17D1 following staining with an antibody
against the cd T cell receptor [6, 8], this technique has
not been successful in identifying Vc6
+ cells in our
laboratory. However, PCR data support the indirect
observation of pulmonary Vc6
+ cells [8]. While this
suggests that both Vc6
+ and Vc2
+ cells are likely to
comprise any remainder of the cd T cell population, a
majority of Vc2 transcripts may be non-productive, as
indicated by spectratype data [23]. Further analysis of
the response did not reveal any apparent differences in
the kinetics of each responding subset. This suggests
that, in contrast with experimental infections such as
listeriosis or schistosomiasis [32–34], there is no initial
cd T cell response associated with anti-bacterial func-
tion.In contrast,the entire responseappearstocorrelate
with the final stages of bacterial clearance and the onset
of the resolution phase.
PCR analysis of naive and challenged mice also
revealed lung-restricted expression of Vc5 mRNA. While
Vc5
+ cells are not completely restricted to the skin
dendritic epithelial T cell population [17, 22, 23],
pulmonary Vc5 mRNA was unexpected. However,
neither spectratype analysis nor flow cytometry, in
agreement with recent data [8], indicated the presence
of any currently defined Vc5
+ population. Non-produc-
tive Vc5 mRNA may be erroneously expressed by, for
example, Vc6
+ cells, as suggested by previous studies
[35–37]. Therefore, lung cd Tcells expressing functional
Vc5 TCR appear to have been excluded.
Vc1
+ and Vc4
+ cells were significantly increased
following S. pneumoniae challenge. Pulmonary Vc1
+
andVc4
+cellshavepreviouslybeenshowntorespondto
both mycobacteria [13] and influenza [11]. While cd
T cell cytokine production is observed in both models,
only mycobacterial challenge induces cd Tcell cytotoxi-
city [12, 13, 28]. In contrast, pneumococcal challenge
induces resolution-associated cytotoxic activity [20]
without coincident ex vivo cytokine expression. Stimula-
tion of cd T cells with PMA and ionomycin revealed no
overall change in the capacity of these cells to produce
specific cytokines following challenge. While these data
suggest increased numbers of cd T cells with cytokine-
producing potential during the inflammatory response,
any role for cd T cell-derived cytokines in the current
model remains to be defined.
It remains unclear whether Vc1
+ and Vc4
+ popula-
tions recognizing similar targets are expanded in these
disparate contexts, suggestive of functional heteroge-
neity dependent on an inflammatory environment
rather than the ligand encountered. Alternatively, each
inflammatory situation may activate distinct popula-
tions of Vc1 and Vc4 cells, each with specific functions.
Despite this first quantification of pulmonary cd T cell
subsets during inflammation, a majority of responding
cd T cells remain undefined by direct observation.
Nevertheless, byimplication from PCR analyses together
with flow cytometric data, S. pneumoniae-induced
inflammation clearly induces substantial quantitative
increases in multiple cd T cell subsets.
The majority of cd T cells from naive lungs
constitutively expressed the activation-associated mar-
kers CD44 and CD69. This apparently high level of
constitutivelyactivatedpulmonarycdTcellsfitswithina
model of cd T cell population maturation in naive
animals [38]. Phenotypically activated, 'naive' cd Tcells
also occur in murine vaginal [39, 40] and intestinal
epithelium [41], but not the spleen of the same
uninfected mice, or in recent thymic emigrants [38].
These data suggest that a mucosal location may closely
associate with an activated status in apparently 'naive'
hosts, although the relationship between activation and
homeostatic function remains to be investigated.
S. pneumoniae challenge further activated the multiple
responding cd T cell subsets in a surprisingly uniform
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example, the Vc1o rV c4 subset, as for Vc6i nb o t h
Listeria[6]and pulmonaryfibrosis[10]models. Inother
systems, cd T cells may up-regulate surface markers
following recognition of Toll-like receptor ligands [42],
or as a result of TNF activity [43], although the
mechanisms driving activation of cd T cells both in
naive lungs and following in vivo pathogen challenge
remain unknown.
Given the tissue-specific nature of certain cd T cell
subsets, it may be assumed that increases in lung cd
Tcells arise from local expansion.While dataconcerning
canonical Vc subsets, including Vc6 in the lung [10],
strongly support this conclusion, other cd T cell subsets
have widespread distributions. Thus, while increased
Vc1 and Vc4 numbers may represent local expansion,
these cells may feasibly migrate to the lung from
draining LN, spleen and other lymphoid tissues. The
current data are the first to directly examine this
alternative, and indicate that local expansion is the
primary source of increased numbers during a poly-
clonal cd T cell response. Following S. pneumoniae
challenge, cell division among cd T cells is significantly
increased in the lung, but not in draining LN or spleen,
and cycling of lung cd T cells has been observed in
response to influenza infection [44]. The inflammatory
environment of the challenged lung may drive both
activation and expansion of resident cd Tcells. The lack
ofsignificantcdTcelldivision,or their increase orlossin
other tissues and blood, supports this model. However,
any potential contribution of thymic emigrant cells,
while of a non-activated phenotype in naive animals
[38], remains to be determined under inflammatory
conditions. While the proportion of cycling (BrdU
+)
lung ab T cells was also increased following challenge,
this is not accompanied by substantial increases in their
number. In contrast to the apparent local expansion of
cd T cells, it is more likely that ab T cells expand in
draining LN and home back to lung tissues. The absence
of substantial quantitative changes suggests that the
current model of rapidly resolving inflammation does
not facilitate the prolonged retention or recruitment of
ab T cells within the lung.
cd T cells from lungs of mice challenged 7 days
previously with S. pneumoniae exhibit a strong pre-
ference in homing to the lung, regardless of the
inflammation state of the tissue. This inflammation
independence contrasts with the homing phenotype
suggested from human in vitro studies [45], and may
reflect the tissue, rather than blood, origin of the cd
T cells. That lung-derived ab T cells from the same
individuals did not exhibit this preference is further
evidence of the tissue-specific nature of both the lung cd
T cell response and of cd T cells in general. Two
important considerations remain under examination
with regard to homing capabilities. First, does each lung
cd T cell subset have equal homing capacity? Further
studies will examine whether lung homing is most
associated with the canonical lung Vc6 subset. Second,
is cd T cell homing to the lung restricted to cells that
originate in the lung, or is it an inflammation-inducible
property of cd T cells in other tissues? To address this
latter point, we attempted to purify activated cd T cells
from the spleen of Listeria-infected mice for transfer
studies. However, it was not possible to purify sufficient
splenic cd T cells due to their strong adherence to
activated splenic macrophages in this model ([46] and
our unpublished data).
In vitro studies of human cdTcells suggest that these
cells have LN-homing capabilities once activated [47],
while others may acquire a tissue-homing phenotype
[45]. It is possible that lung cd Tcells may be 'imprinted'
for lung homing either during development or activa-
tion, as occurs for ab T cells in the intestinal mucosa
[48]. The mechanisms governing lung-specific cd T cell
homing are the subject of ongoing study, although
expression of the commonly mucosal lymphocyte-
associated integrin CD103 by pulmonary cd T cells
has not been observed (our unpublished observations).
Together these studies provide further evidence for
the tissue- and context-specific nature of cd T cell
responses. However, they also serve to highlight the
paucity of knowledge concerning cd Tcell behavior and
its regulation. By further examination of the activation
processes and tissue-specific regulatory mechanisms to
which cd T cells are subject, a much better under-
standing of this important, immunoregulatory T cell
population will emerge.
Materials and methods
Mice and S. pneumoniae infection
C57BL/6 (B6.CD45.2) and B6.CD45.1 mice were bred and
housed under barrier conditions at LSHTM and the University
ofYork,andsuppliedwith food andwateradlibitum.Duringin
vivo labeling experiments, drinking water was supplemented
with BrdU (Sigma) at 0.8 mg/mL, freshly prepared daily. Mice
were infected intranasally with approximately 10
8 CFU of
S. pneumoniae serotype 6B as described [18, 19]. Animal
experimentation was performed with LSHTM and the
University of York Animal Procedures Ethics Committee and
UK Home Office approval.
Tissue preparation
Whole organs were collagenase-digested to single-cell suspen-
sions as described [18]. Viable cell counts were determined by
Trypan blue exclusion.
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Flow cytometry was carried out as described [18], using the
following antibody clones (all BD Pharmingen): GL3 (TCRd),
536 (Vc5), UC310A6 (Vc4), 8F4H7B7 (Vd6.3), 145.2C11
(CD3), H57–597 (TCRb), GK1.5 (CD4), 53–6.7 (CD8a),
RA3.6B2 (B220), PC61 (CD25), IM7 (CD44), H1.2F3
(CD69), A20 (CD45.1), XT22 (TNF), C15.6 (IL-12 p40/70,
IL-23), JES5–16E3 (IL-10), XMG1.2 (IFN-c),11B11 (IL-4), and
appropriate isotype controls. AlexaFluor488 (Molecular
Probes)-conjugated F(ab')2 fragments of GL3, 2.11 (Vc1)
andUC310A6werepreparedin-house(hybridomasgenerously
provided by P. Pereira, Institut Pasteur, Paris, France). BrdU
was detected using FITC-conjugated anti-BrdU antibody
(clone B44; BD Pharmingen), according to standard protocols
[38]. Intracellular cytokine staining followed a 4-h incubation
with brefeldin A alone (Sigma) as described [49], or in the
presence of PMA and ionomycin. All samplesweretreated with
anti-FcRII/III mAb (clone 2.4G2) prior to specific staining.
Samples were acquired on a FACSCalibur flow cytometer and
analyzed with CellQuest Pro software (both Becton Dickinson,
Oxford, UK), or on a Cyan flow cytometer and analyzed with
Summit v4.1 software (both DakoCytomation).
For flow cytometric sorting, whole lung preparations were
enriched for Tcells using biotinylated anti-CD3 antibody, anti-
biotin beads and MACS sorting (Miltenyi Biotech, Germany).
Subsequent purification of cd and ab Tcells was carried out on
a MoFlo cell sorter (DakoCytomation). Purity of sorted
populations was confirmed by flow cytometry as >95% in
each case.
Adoptive transfer
Sorted cd or ab T cells were labeled by incubation in 5 lM
CFSE for 10 min at room temperature, washed extensively and
resuspended in PBS. Mice received 10
6 donor cells intrave-
nously.
PCR and spectratype analysis
RT-PCR analysis of Vc chain expression, and subsequent
spectratyping of PCR products, was carried out on mRNA
extracted from whole organ preparations, or from sorted cell
populations derived from pooled organs of three to six
individuals, as described [23].
Statistical analysis
Where indicated, data were compared using Student's two-
tailed t-test.
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